Study of the tetanus vaccine vax-TET®-5 |
CIGB-247 vaccine in patients with solid malignant tumors, phase I, randomized. (CENTAURO-2 study) |
Transthoracoscopic Sympathectomy T-3 and T-4 in moderate palmar Hyperhidrosis . |
Vidatox 30CH in advanced malignant tumors-Primary health care-Phase IV |
Diphenhydramine previous to CIGB-300 in cervical carcinoma (CERVISEG-II Study) |
Zolpidem to treat disorders of consciousness |
Inmunogenicity-PCV-Carriage-Venezuelan High Risk Children |
ior EPOCIM ® in the management of anemia of the preterm infant.Phase IV. |
Pharmacokinetics of the Intralesional administration of rhEGF (doses: 75 µg and 225 µg) in advance Diabetic Foot Ulcers |
Interferon Combination in basal cell carcinoma (InCarbacel-V study) |
Nimotuzumab for the treatment of high grade of malignancy tumors |
Nimotuzumab in tumors of head and neck .Phase IV |
Squamous cell carcinoma interferons (CECIN study) |
Safety with interferon in skin carcinomas (SCIENCE study) |
Biodistribution of CIGB-300 in cervical cancer (CERVIFARM-300-II Study) |
Safety and Pharmacology of CIGB-300 in cervical cancer (CERVIFARM-300 Study) |
Intravenous CIGB-128-A in patients with brain tumors (BRATINC Study) |
Subcutaneous immunotherapy with PROLINEM -Asthma- Adults-Fase I |
D-004 in patients with Bening Prostatic Hyperplasia |
NASVAC Phase II Trial in patients with Chronic Hepatitis B Virus infection |